Shared CD8+ T cell receptors for SARS-CoV-2


Using a high-throughput approach, Snyder et al. profile clonally expanded SARS-CoV-2-specific CD8+ T cells both at the individual level, mapping T cell receptors (TCRs) to 545 predicted HLA class I-binding peptides in 61 acute and convalescent patients with COVID-19, and at the population level, decoding shared COVID-19-associated TCRs in 1,015 patients versus control subjects. In total, this preprint identifies 23,179 unique virus-specific TCRs spanning the entire SARS-CoV-2 proteome. Importantly, HLA haplotypes were found to determine both clonal breadth and depth of an individual’s virus-specific CD8+ T cell response. By applying a logistic regression classifier, the authors show that publicly shared CD8+ TCRs may be used as a potential biomarker of current and past SARS-CoV-2 infection at high specificity and sensitivity.


Original article

  1. Snyder, T. M. et al. Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels. Preprint at medRxiv (2020)

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information



Corresponding authors

Correspondence to Rachel Levantovsky or Verena van der Heide.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Levantovsky, R., van der Heide, V. Shared CD8+ T cell receptors for SARS-CoV-2. Nat Rev Immunol 20, 591 (2020).

Download citation

Further reading


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing